Highlights – 3rd Quarter 2010
Total revenues increase 25% to record EUR 2.4 billion
Profit after tax rises 45% to EUR 215 million
Rebif® sales +6.8% to EUR 407 million
Erbitux® sales +17% to EUR 207 million
Liquid Crystals revenues up 21% to EUR 255 million
Guidance for 2010: Group core operating result lifted to 58%
Millipore acquisition completed, figures consolidated in Q3
Total revenues
Operating result
by quarterEUR million
Total revenues by quarter (bar chart)

SERVICES

DOWNLOADS

Download PDF (2.7 MB) Download XLS (0.1 MB)

ANNUAL REPORT 2009

Read the Annual Report online
 
Imprint, © Merck KGaA, Darmstadt, Germany, Last Update 2010/10/26